Increased Risk of Telogen Effluvium with Tirzepatide Compared to Other Weight-Loss Medications: A Retrospective Cohort TriNetX Database Study

    August 2025 in “ Journal of the American Academy of Dermatology ”
    Zachary Neubauer, Michael M Ong, Amit Singal, Shari R. Lipner
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on linkinghub.elsevier.com →
    Discuss this study in the Community →